Outlook Business18h
Hetero Inks Voluntary Licensing Pact with Gilead for HIV Drug Lenacapavir
Hetero has partnered with Gilead Sciences to manufacture and distribute the HIV drug lenacapavir in 120 low- and ...
The Financial Express16h
Hetero enters into agreement with Gilead to manufacture and distribute multi drug-resistant HIV
Lenacapavir was approved for use in HIV-positive adults with multi-drug resistance by the European Union in August 2022 and ...
Dr Reddy's, Hetero ink royalty-free voluntary licencing pacts with Gilead Sciences for HIV drug Lenacapavir
Dr Reddy's Laboratories and Hetero, along with other generic drug makers, enter into voluntary licensing agreements with ...
Dr. Reddy’s and Hetero join hands with Gilead to broaden access to HIV drug Lenacapavir in low-income countries
Dr. Reddy’s and Hetero partner with Gilead Sciences to manufacture and distribute Lenacapavir for HIV treatment in LMICs.
Dr Reddy’s, Hetero ink royalty-free pact with Gilead
Dr Reddy's Laboratories and Hetero sign non-exclusive, royalty-free agreements with Gilead Sciences to manufacture ...
money.rediff1d
Hetero & Gilead Partner for HIV Drug Lenacapavir Access
Hetero and Gilead have partnered to expand access to lenacapavir, a groundbreaking HIV treatment, in 120 low- and ...
My Hetero Hunk of a French Lover Asked Me to F*ck Him Like a Woman
With women, as Étienne had somehow sensed, I’m a very attentive, confident, and giving top. My pleasure comes mostly from ...
Indian pharma firms ink deal with U.S. drug maker Gilead to make, market generic HIV drug lenacapavir
Dr. Reddy's, Hetero, and Mylan partner with Gilead Sciences to manufacture generic lenacapavir for HIV prevention globally.
Dr Reddy's, Hetero sign voluntary licenses with Gilead for HIV drug
Gilead Sciences first launched lenacapavir under the brand name Sunlenca in the United States and European markets in 2022. It is a first-in-class HIV-1 capsid inhibitor ...
Interesting Engineering3h
Perovskite cells offer 23.69% power conversion rate with defect passivation method
A study led by the Gwangju Institute of Science and Technology (GIST) developed the new defect passivation strategy. The ...
pv magazine International14h
Perovskite solar module achieves 21.44% efficiency via new passivation tech
Researchers have developed a novel passivation process for formamidinium lead iodide perovskite films, which reportedly ...